Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer

PURPOSE: Targeting the PD-1/PD-L1 pathway has emerged as a novel therapy for cancer. To identify rational candidates for anti-PD-1/PD-L1 immunotherapy in gastric cancer (GC), the abundance of PD-L1 expression was evaluated on a kind of biomarker-based molecular classification for shaping prognosis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yeqi, Yu, Wenwei, Guan, Wenbin, Cai, Lei, Qiao, Meng, Zheng, Leizhen, Jiang, Ruiqi, Wang, Ruifen, Wang, Lifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630096/
https://www.ncbi.nlm.nih.gov/pubmed/31372044
http://dx.doi.org/10.2147/CMAR.S206189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630096/
https://www.ncbi.nlm.nih.gov/pubmed/31372044
http://dx.doi.org/10.2147/CMAR.S206189

Ejemplares similares